INTRO

INTRO
KOR
CHN

GemVax & KAEL

GemVax & KAEL will take a leap as a global pharmaceutical company leading world healthcare industry

  • vision

    Human respect and trustworthy
    enterprise valuing quality of human life

  • history

    GemVax’s steps for new drug
    development

About US

ABOUT RIAVAX™ inj.

RIAVAX™ is telomerase-derived immunotherapeutic peptide for treatment of pancreatic cancer.

PRODUCT

STORY OF RIAVAX™ inj.

RIAVAX™ is 21ST Korean new drug which received a marketing and manufacturing authorization from Ministry of Food and Drug Safety for treatment of pancreatic cancer


RESEARCH & DEVELOPMENT

GemVax™ has been actively pursuing research and development of novel therapeutic drugs exhibiting superior safety and efficacy based on the proven technologies demonstrated from development of RIAVAX™

OUR STORY

GemVax & KAEL pledges to carry out our responsibility in healthcare industry to devote to healthy lives and to improve quality of human life.